Literature DB >> 9373915

Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits.

S C Kim1, I K Kim, K K Seo, K J Baek, M Y Lee.   

Abstract

Involvement of the superoxide radical in impaired relaxation of penile cavernous smooth muscle in hypercholesterolemia was investigated. New Zealand White rabbits (n = 40) were randomly divided into control and treatment groups. The control group (n = 20) received a regular diet while the treatment group (n = 20) was fed a diet of 2% cholesterol for 8 weeks. Blood level of cholesterol in the cholesterol-fed group was significantly higher than that of the control group. The contraction responses of cavernous tissues to norepinephrine were not significantly different in the two groups. The relaxation responses to endothelium-dependent agents (acetylcholine, bradykinin) were significantly reduced in the hypercholesterolemic group compared with the control group. However, the relaxation responses to endothelium-independent agents (papaverine, verapamil) were not significantly different in the two groups. The production of superoxide radicals was significantly higher in the hypercholesterolemic group than in the control group (P < 0.01). The activity of superoxide dismutase (total SOD, Mn-SOD, Cu,Zn-SOD) increased significantly in the hypercholesterolemic group compared with the control group (P < 0.05). The activities of catalase and glutathione peroxidase also increased in the hypercholesterolemic group, but were not significantly higher than those of the control group. Therefore, production of the superoxide radicals in rabbit cavernous tissues increases in the state of hypercholesterolemia, which may lead to functional impairment of cavernous smooth muscle relaxation in response to endothelium-mediated stimuli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373915     DOI: 10.1007/bf01294663

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

2.  Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Travis D Strong; Sena F Sezen; Justin M Johnson; Arthur L Burnett
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

3.  Low-fat diet and exercise preserve eNOS regulation and endothelial function in the penis of early atherosclerotic pigs: a molecular analysis.

Authors:  Biljana Musicki; Tongyun Liu; Travis Strong; Liming Jin; M Harold Laughlin; James R Turk; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-01-10       Impact factor: 3.802

Review 4.  NADPH oxidase: recent evidence for its role in erectile dysfunction.

Authors:  Liming Jin; Arthur L Burnett
Journal:  Asian J Androl       Date:  2008-01       Impact factor: 3.285

5.  The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemia.

Authors:  Hoon Jang; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Seung Mo Yuk; Dong Seok Han; Chang Shik Youn; Eun Bi Kwon; Sung Yeoun Hwang; Sae Woong Kim
Journal:  BMC Complement Altern Med       Date:  2017-02-24       Impact factor: 3.659

Review 6.  Is there a link between soft drinks and erectile dysfunction?

Authors:  Jan Adamowicz; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2011-09-06

7.  Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana Pereira Costa-Fraga; Fabrizio Montecucco; Younouss Faye; Silvia Quintao Savergnini; Sébastien Lenglet; François Mach; Sabine Steffens; Nikolaos Stergiopulos; Robson Augusto Souza dos Santos; Rafaela Fernandes da Silva
Journal:  Clin Dev Immunol       Date:  2013-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.